INTRODUCTION: Data obtained in completed Alzheimer's disease (AD) clinical trials can inform decision making for future trials. Recognizing the importance of sharing these data, the Coalition Against Major Diseases created an Online Data Repository for AD (CODR-AD) with the aim of supporting accelerated drug development. The aim of this study was to build an open access, standardized database from control arm data collected across many clinical trials. METHODS: Comprehensive AD-specific data standards were developed to enable the pooling of data from different sources. Nine member organizations contributed patient-level data from 24 clinical trials of AD treatments. RESULTS: CODR-AD consists of control arm pooled and standardized data from 24 trials currently numbered at 6500 subjects; Alzheimer's Disease Assessment Scale-cognitive subscale 11 is the main outcome and specific covariates are also included. DISCUSSION: CODR-AD represents a unique integrated standardized clinical trials database available to qualified researchers. The pooling of data across studies facilitates a more comprehensive understanding of disease heterogeneity.
INTRODUCTION: Data obtained in completed Alzheimer's disease (AD) clinical trials can inform decision making for future trials. Recognizing the importance of sharing these data, the Coalition Against Major Diseases created an Online Data Repository for AD (CODR-AD) with the aim of supporting accelerated drug development. The aim of this study was to build an open access, standardized database from control arm data collected across many clinical trials. METHODS: Comprehensive AD-specific data standards were developed to enable the pooling of data from different sources. Nine member organizations contributed patient-level data from 24 clinical trials of AD treatments. RESULTS: CODR-AD consists of control arm pooled and standardized data from 24 trials currently numbered at 6500 subjects; Alzheimer's Disease Assessment Scale-cognitive subscale 11 is the main outcome and specific covariates are also included. DISCUSSION: CODR-AD represents a unique integrated standardized clinical trials database available to qualified researchers. The pooling of data across studies facilitates a more comprehensive understanding of disease heterogeneity.
Authors: Scott C Neu; Judy Pa; Walter Kukull; Duane Beekly; Amanda Kuzma; Prabhakaran Gangadharan; Li-San Wang; Klaus Romero; Stephen P Arneric; Alberto Redolfi; Daniele Orlandi; Giovanni B Frisoni; Rhoda Au; Sherral Devine; Sanford Auerbach; Ana Espinosa; Mercè Boada; Agustín Ruiz; Sterling C Johnson; Rebecca Koscik; Jiun-Jie Wang; Wen-Chuin Hsu; Yao-Liang Chen; Arthur W Toga Journal: JAMA Neurol Date: 2017-10-01 Impact factor: 18.302
Authors: Diane Stephenson; Michele T Hu; Klaus Romero; Kieran Breen; David Burn; Yoav Ben-Shlomo; Atul Bhattaram; Maria Isaac; Charles Venuto; Ken Kubota; Max A Little; Stephen Friend; Simon Lovestone; Huw R Morris; Donald Grosset; Margaret Sutherland; John Gallacher; Caroline Williams-Gray; Lisa J Bain; Enrique Avilés; Ken Marek; Arthur W Toga; Yafit Stark; Mark Forrest Gordon; Steve Ford Journal: J Parkinsons Dis Date: 2015 Impact factor: 5.568
Authors: Stephen P Arnerić; Richard Batrla-Utermann; Laurel Beckett; Tobias Bittner; Kaj Blennow; Leslie Carter; Robert Dean; Sebastiaan Engelborghs; Just Genius; Mark Forrest Gordon; Janice Hitchcock; June Kaplow; Johan Luthman; Richard Meibach; David Raunig; Klaus Romero; Mahesh N Samtani; Mary Savage; Leslie Shaw; Diane Stephenson; Robert M Umek; Hugo Vanderstichele; Brian Willis; Susan Yule Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Jon Neville; Steve Kopko; Klaus Romero; Brian Corrigan; Bob Stafford; Elizabeth LeRoy; Steve Broadbent; Martin Cisneroz; Ethan Wilson; Eric Reiman; Hugo Vanderstichele; Stephen P Arnerić; Diane Stephenson Journal: Alzheimers Dement (N Y) Date: 2017-04-15
Authors: Junko Takata; Paul Sondo; Georgina S Humphreys; Rebekah Burrow; Brittany Maguire; Mohammad S Hossain; Debashish Das; Robert J Commons; Ric N Price; Philippe J Guerin Journal: Am J Trop Med Hyg Date: 2020-05-07 Impact factor: 2.345
Authors: Lynn D Hudson; Rebecca D Kush; Eileen Navarro Almario; Nathalie Seigneuret; Tammy Jackson; Barbara Jauregui; David Jordan; Ronald Fitzmartin; F Liz Zhou; James K Malone; Jose Galvez; Lauren B Becnel Journal: Clin Transl Sci Date: 2018-04-26 Impact factor: 4.689